NEW YORK--(BUSINESS WIRE)--Deutsche Bank announced today its appointment as depositary bank for the AmericanDepositaryReceipt program of Radiopharm Theranostics Limited. Radiopharm ...
In the completed Phase 1/2a clinical trial (NCT03715985), assessing EVX-01 in combination with a PD-1 inhibitor, eight of twelve metastatic melanoma patients (67%) had objective clinical responses ...
Deutsche bank today announced the lineup for its Depositary Receipts Virtual Investor conference (“dbVIC”) on Tuesday, September 24 and Wednesday, September 25, featuring live webcast presentations ...